167 related articles for article (PubMed ID: 30240898)
1. Perioperative Management of Women Undergoing Risk-reducing Surgery for Hereditary Breast and Ovarian Cancer.
AlHilli MM; Al-Hilli Z
J Minim Invasive Gynecol; 2019 Feb; 26(2):253-265. PubMed ID: 30240898
[TBL] [Abstract][Full Text] [Related]
2. How to manage BRCA mutation carriers?
Sabiani L; Barrou J; Mathis J; Eisinger F; Bannier M; Lambaudie E; Houvenaeghel G
Horm Mol Biol Clin Investig; 2020 May; 41(3):. PubMed ID: 32459193
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer.
Schrauder MG; Brunel-Geuder L; Häberle L; Wunderle M; Hoyer J; Reis A; Schulz-Wendtland R; Beckmann MW; Lux MP
Breast; 2017 Apr; 32():186-191. PubMed ID: 28214786
[TBL] [Abstract][Full Text] [Related]
4. Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia.
Ložar T; Žgajnar J; Perhavec A; Blatnik A; Novaković S; Krajc M
Eur J Surg Oncol; 2021 Aug; 47(8):1900-1906. PubMed ID: 33812767
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.
Kearton S; Wills K; Bunting M; Blomfield P; James PA; Burke J
Fam Cancer; 2018 Jul; 17(3):333-344. PubMed ID: 29039136
[TBL] [Abstract][Full Text] [Related]
6. Surgical Management of Hereditary Breast Cancer.
Berger ER; Golshan M
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573353
[TBL] [Abstract][Full Text] [Related]
7. Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.
Hirasawa A; Masuda K; Akahane T; Tsuruta T; Banno K; Makita K; Susumu N; Jinno H; Kitagawa Y; Sugano K; Kosaki K; Aoki D
Jpn J Clin Oncol; 2013 May; 43(5):515-9. PubMed ID: 23487443
[TBL] [Abstract][Full Text] [Related]
8. A new strategy for prophylactic surgery in BRCA women: Combined mastectomy and laparoscopic salpingo-oophorectomy with immediate reconstruction by double DIEP flap.
Hunsinger V; Marchac AC; Derder M; Hivelin M; Lecuru F; Bats AS; Lantieri L
Ann Chir Plast Esthet; 2016 Jun; 61(3):177-82. PubMed ID: 26946931
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with intentions for breast cancer risk management: Does risk group matter?
Conley CC; Agnese DM; Vadaparampil ST; Andersen BL
Psychooncology; 2019 May; 28(5):1119-1126. PubMed ID: 30889627
[TBL] [Abstract][Full Text] [Related]
10. Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.
Ludwig KK; Neuner J; Butler A; Geurts JL; Kong AL
Am J Surg; 2016 Oct; 212(4):660-669. PubMed ID: 27649974
[TBL] [Abstract][Full Text] [Related]
11. Hereditary Women's Cancer: Management and Risk-Reducing Surgery.
Conte C; Pelligra S; Sarpietro G; Montana GD; Della Corte L; Bifulco G; Martinelli C; Ercoli A; Palumbo M; Cianci S
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837501
[TBL] [Abstract][Full Text] [Related]
12. Challenging and complex decisions in the management of the BRCA mutation carrier.
Stan DL; Shuster LT; Wick MJ; Swanson CL; Pruthi S; Bakkum-Gamez JN
J Womens Health (Larchmt); 2013 Oct; 22(10):825-34. PubMed ID: 23987739
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers.
Shaw PA; Clarke BA
Surg Pathol Clin; 2016 Jun; 9(2):307-28. PubMed ID: 27241111
[TBL] [Abstract][Full Text] [Related]
15. [Cost-effectiveness of risk-reducing salpingo-oophorectomy in cases of BRCA1 gene mutation in Colombia].
González-Mariño MA
Rev Salud Publica (Bogota); 2018; 20(2):232-236. PubMed ID: 30570007
[TBL] [Abstract][Full Text] [Related]
16. Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers.
Laitman Y; Vaisman Y; Feldman D; Helpman L; Gitly M; Paluch Shimon S; Berger R; Cohen L; Narod SA; Friedman E
Clin Genet; 2014 Jan; 85(1):68-71. PubMed ID: 23517234
[TBL] [Abstract][Full Text] [Related]
17. Management of ovarian cancer risk in women with
Walker M; Jacobson M; Sobel M
CMAJ; 2019 Aug; 191(32):E886-E893. PubMed ID: 31405835
[No Abstract] [Full Text] [Related]
18. Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.
Casey MJ; Colanta AB
Fam Cancer; 2016 Jul; 15(3):371-84. PubMed ID: 26875157
[TBL] [Abstract][Full Text] [Related]
19. Management of hereditary breast and ovarian cancer.
Yamauchi H; Takei J
Int J Clin Oncol; 2018 Feb; 23(1):45-51. PubMed ID: 29185095
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Care of Women With Genetic Predisposition to Breast and Ovarian Cancer.
AlHilli MM; Batur P; Hurley K; Al-Hilli Z; Coombs D; Schwarz G; Djohan R; Marquard J; Ashton K; Pederson HJ
Mayo Clin Proc; 2023 Apr; 98(4):597-609. PubMed ID: 36870859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
